2021
DOI: 10.1016/j.apradiso.2021.109965
|View full text |Cite
|
Sign up to set email alerts
|

Estimation of patient effective doses in PET/CT- 18F-Sodium Fluoride examinations

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 20 publications
0
3
0
Order By: Relevance
“…Although radiation is not evenly distributed globally, the number of diagnostic nuclear medicine exams yearly is rising [3] [4] [5]. For most NM examinations, the mean effective dose per NM examination ranges from 0.3 to 20.0 mSv [6]- [13]. The development of the 99Mo/99mTc generating set and γ-camera in the 1950s allowed for the performance of bone scanning techniques by clinicians [14] (Stefanofic, 2001).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Although radiation is not evenly distributed globally, the number of diagnostic nuclear medicine exams yearly is rising [3] [4] [5]. For most NM examinations, the mean effective dose per NM examination ranges from 0.3 to 20.0 mSv [6]- [13]. The development of the 99Mo/99mTc generating set and γ-camera in the 1950s allowed for the performance of bone scanning techniques by clinicians [14] (Stefanofic, 2001).…”
Section: Introductionmentioning
confidence: 99%
“…NM involves handling radioactive substances that can expose staff to radiation both internally and externally as a result of radiopharmaceutical elusions and preparation in specially protected laboratory (hot lab). The staff was also exposed to ionizing radiation for the period of administering 99mTc to patients and after the scanning that poses radiogenic hazard for NM personnel [6] [7] [8] [9]. Therefore, depending on workload and procedure approach, areas of the body not covered with the leaded apron might be exposed to unavoidable exposure resulted from ionizing radiation sources.…”
Section: Introductionmentioning
confidence: 99%
“…7,8 Recently, in addition to oncologic applications, the diagnostic potential of NaF-PET in monitoring benign bone diseases has been increasingly appreciated. 5,[9][10][11] Although the radiation exposure from NaF-PET/CT (effective dose up to 10 mSv 12 ) is greater than that of dualenergy x-ray absorptiometry (DXA; effective dose up to 0.01 mSv 13 ) and quantitative CT (effective dose up to 3 mSv 13 ), a validated method of using NaF-PET/CT to evaluate metabolic bone disease could facilitate more opportunities for osteoporosis screening among patients undergoing imaging for cancer staging or restaging. Furthermore, clinical trials of novel therapeutic agents that aim to modulate osteoblastic activity to treat metabolic bone disease require precise and accurate metrics to characterize drug effects.…”
mentioning
confidence: 99%